Shares Outstanding History
Cash Position
Cash Position
The company has -20.1 months of cash left based on the quarterly cash burn of $-3.93 M and estimated current cash of $-26.28 M.
Commentary on Financial Condition
“To date, we have not generated any revenue from product sales. During the years ended December 31, 2024, and 2023, we have generated a limited amount of revenue through the achievement of contractually stated milestones as well as grants, and the performance of services from collaboration agreements, including through our ActivMAb platform. Since our inception in 2001, we have relied on public and private sales of equity and debt financing to fund our operations, in addition to capital contributions from noncontrolling interests and limited-service revenue from collaboration agreements, and to some degree, grant money. We are not a party to any material off-balance sheet arrangements as defined in the rules and regulations of the SEC. In 2024 the Company received aggregate gross proceeds of approximately $15.8 million from (i) private placements of 510,774 shares of common stock, 675,009” (from April 2025 filing’s Liquidity and Capital Resources) Filed At: 2025-04-15
| 10-K | Form 10-K | 2025-04-15 |
| NT 10-K | Form NT 10-K | 2025-04-01 |
| 15-12G | Form 15-12G | 2025-03-27 |
| EFFECT | Form EFFECT | 2025-03-26 |
| EFFECT | Form EFFECT | 2025-03-26 |
| EFFECT | Form EFFECT | 2025-03-26 |
| EFFECT | Form EFFECT | 2025-03-26 |
| EFFECT | Form EFFECT | 2025-03-26 |